New Drug Research

Drug Candidate Screening

NEXEL Co., Ltd. is developing safe and efficient drug development candidates derived from bioactive proteins secreted by hiPSC-derived functional cells.

NEXEL Pipeline

<Last update: May. 2022>

Drug Candidate Screening
  • logoCONTACT

    Contact Information

    • Address: 8F, 55 Magokdong-ro, Gangseo-gu, Seoul, Republic of Korea(07802)

    • Business Registration No.: 109-86-37282
    • CEO: Choongseong Han

    • Tel: +82-2-2088-8886
    • Fax: +82-2-2088-8884
    • E-mail: support@nexel.co.kr